Fiverr International (NYSE:FVRR) and Protagenic Therapeutics (OTCMKTS:PTIX) are both retail/wholesale companies, but which is the superior stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation.
Valuation & Earnings
This table compares Fiverr International and Protagenic Therapeutics’ top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Fiverr International||$107.07 million||20.43||-$33.54 million||($1.18)||-59.82|
|Protagenic Therapeutics||N/A||N/A||-$1.75 million||N/A||N/A|
Protagenic Therapeutics has lower revenue, but higher earnings than Fiverr International.
This is a summary of current ratings and target prices for Fiverr International and Protagenic Therapeutics, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Fiverr International currently has a consensus price target of $51.75, indicating a potential downside of 26.69%. Given Fiverr International’s higher probable upside, equities research analysts clearly believe Fiverr International is more favorable than Protagenic Therapeutics.
Insider & Institutional Ownership
49.4% of Fiverr International shares are held by institutional investors. 41.0% of Protagenic Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
This table compares Fiverr International and Protagenic Therapeutics’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Fiverr International Company Profile
Fiverr International Ltd. operates an online marketplace worldwide. Its platform enables sellers to sell their services and buyers to buy them. The company's platform includes approximately 200 categories in 8 verticals, including graphic and design, digital marketing, writing and translation, video and animation, music and audio, programming and technology, business, and lifestyle. Its buyers include businesses of various sizes, as well as sellers comprise a group of freelancers and small businesses. The company was founded in 2010 and is based in Tel Aviv, Israel.
Protagenic Therapeutics Company Profile
Protagenic Therapeutics, Inc., a biotechnology company, engages in the discovery and development of therapeutics to treat central nervous system disorders. Its lead drug candidate is PT00114, which is in clinical proof-of-concept studies for the treatment-resistant depression and/or post-traumatic stress disorder. The company is based in New York, New York.
Receive News & Ratings for Fiverr International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fiverr International and related companies with MarketBeat.com's FREE daily email newsletter.